Shilpa Medicare P/E Ratio

SHILPAMED • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
48.79
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 48.79
Current Price ₹391.35
EPS (TTM) ₹8.04
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 52.52
Historical Range 15.79 - 113.35
Percentile 50.0%

Sector Context

Sector Average 47.48
Sector Median 25.5
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹14.13
Sept 2025 ₹5.50
Mar 2025 ₹1.48

Key P/E Ratio Insights for Shilpa Medicare

  • Stock appears overvalued with PE of 48.79, suggesting caution for new investments

P/E Ratio Historical Trend for Shilpa Medicare

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 59.35 14.13 ₹838.65 NSE High
2024 87.22 9.36 ₹816.35 BSE High
2021 113.35 4.73 ₹536.15 BSE High
2020 21.1 21.34 ₹450.25 BSE Moderate
2019 15.79 17.84 ₹281.75 BSE Moderate
2018 26.04 14.75 ₹384.05 BSE High
2017 45.35 13.6 ₹616.80 BSE High
2016 51.94 13.19 ₹685.10 BSE High

Sector P/E Ratio Comparison

Comparing Shilpa Medicare with other companies in Healthcare sector
Sector Average
47.48
Sector Median
25.5
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.83 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.53 ₹1,133 Low
Amwill Health Care AMWILL 5.67 ₹64 Low
Brooks Laboratories BROOKS 6.14 ₹157 Low
Medicamen Organics MEDIORG 6.4 ₹27 Low
Zenith Drugs ZENITHDRUG 6.83 ₹69 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Galaxy Medicare GML 7.41 ₹26 Low
Vasundhara Rasayans VRL 9.35 ₹34 Low